Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Article
Immunotherapy evolves as melanoma treatment
In his presentation at the AAD annual meeting yesterday, Henry C. Maguire,Jr., M.D., reviewed the history, current practice, and future prospectsfor the immunotherapy of cutaneous melanoma. The response of melanoma toradiation therapy or to chemotherapy is poor; cures of metastatic melanomathat cannot be controlled by surgery are rare. It is hoped that immunotherapycan fill this therapeutic gap.
Related Videos
Related Content
